[1] |
Zhou QH, Liu LX, Che GW. A randomized clinical trial of preoperative neoadjuvant chemotherapy followed by surgery in the treatment of stage Ⅲ[J]. Zhongguo Fei Ai , 2001, 4(4): 25 1-6.[周清华, 刘伦旭, 车国卫, 等. 术前新辅助化疗加外科手 术治疗Ⅲ期非小细胞肺癌的随机对照临床试验[J]. 中国肺癌, 20 01, 4(4): 251-6.]
|
[2] |
Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases[J]. Ann Oncol, 2002, 13(7) : 1087-93.
|
[3] |
Hsu LH, Chu NM, Liu CC, et al. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor[J]. Lung Cancer, 2009, 66(2): 26 2-7.
|
[4] |
Wu XY, Zhang CM, Ge XP, et al. Investigation and analysis on the survival duration and influencing factors of primary lung cancer in the urban area of Beijing[J]. Beijing Yi Xue, 2009, 31(1): 20-3. [吴新悦, 张城敏, 葛秀平, 等. 北京市1272例原发性肺癌生存时 间及影响因素调查分析[J]. 北京医学,2009, 31(1): 20-3.]
|
[5] |
O’Connell JP, Kris MG, Gralla RJ, et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy[J]. J Clin Oncol,1986,4(11):1604-14.
|
[6] |
Wu MN, Wang YY, An PT, et al. Analysis of prognostic factors in 54 1 female patients with advanced non-small cell lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2011, 14(3): 245-50. [吴梅娜, 王玉艳, 安彤同, 等. 541例女性晚期非小细胞肺癌患者的预后因素分析 [J] 中国肺癌杂志, 2011, 14(3): 245-50.]
|
[7] |
Zhang CM, Zhu GD, Xiao YH, et al. Evaluation on quality of life in women lung cancer patients and analysis of affecting factor[J]. Lin Chuang Fei Ke Za Zhi, 2011, 16(1): 78-80. [张翠敏, 朱贵东, 肖永红. 女性肺癌患者生存质量评价及影响因素分析[J]. 临床 肺科杂志, 2011, 16(1): 78-80.]
|
[8] |
Wei W, Hua D. Prognostic factors in patients with non-small cell lung cancer[J]. Xian Dai Zhong Liu Yi Xue, 2008, 16(9): 15 49-51.[魏巍, 华东. 非小细胞肺癌预后影响因素分析[J].现代 肿瘤医学, 2008, 16(9): 1549-51.]
|
[9] |
Shi MX, Xu GZ, Gao J, et al. Sex effect on prognosis after lung cancer operation[J]. Xian Dai Zhong Liu Yi Xue, 2004, 12(1): 36 -7. [施民新, 许广照, 高俊, 等. 性别对肺癌术后预后的影响 [J] 现代肿瘤医学, 2004, 12(1): 36-7.]
|
[10] |
Donington JS, Le QT, Wakelee HA. Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response[J]. Clin Lung Cancer, 2006, 8(1): 22-9.
|
[11] |
Yang SL, Zhou XY, Pang J, et al. Gender-associated differences in clinical characteristics and prognosis of patients with primary lung cancer[J]. Sichuan Yi Xue, 2012, 33(7): 1304-6.[杨胜利, 周 雪宇, 庞洁, 等. 女性原发性肺癌临床和预后特征与男性差异的 分析[J] , 四川医学, 2012, 33(7): 1304-6.]
|
[12] |
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009, 59(4): 225-49.
|
[13] |
Kiyohara C, Ohno Y. Sex differences in lung cancer susceptibility: a review[J]. Gend Med, 2010, 7(5): 381-401.
|
[14] |
Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases[J]. Ann Oncol, 2002, 13(7): 1087-93.
|
[15] |
Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13 010 resected lung cancers[J]. J Thorac Oncol, 2008, 3(1): 46-52.
|
[16] |
Pe?alver JC, Padilla J, Jordá C, et al. Use of blood products in patients treated surgically for stage I non-small cell lung cancer[J]. Arch Bronconeumol, 2005, 41(9): 484-8.
|
[17] |
Padilla J, Calvo V, Pe?alver JC, et al. Stage Ⅰ non-small cell lung cancer up to 3cm in diameter. Prognostic factors[J]. Arch Bronconeumol, 2004, 40(3): 110-3.
|
[18] |
Nosotti M, Rebulla P, Riccardi D, et al. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage Ⅰ lung cancer[J]. Chest, 2003, 12 4(1): 102-7.
|
[19] |
Kim JS, Kim JW, Han J, et al. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer[J]. Cancer Res, 2006, 66 (8): 4049-54.
|
[20] |
Chen QK, Ding JA, Gao W. Skip metastasis to mediastinal lymph nodes: clinical significance and prognosis in stage Ⅲ non-small cell lung cancer[J]. Zhonghua Jie He He Hu Xi Za Zhi, 2005, 28 (7): 472-4.[陈乾坤, 丁嘉安, 高文. Ⅲ期非小细胞肺癌纵隔淋 巴结跳跃式转移的临床意义[J]. 中华结核和呼吸杂志, 2005, 28 (7): 472-4.]
|
[21] |
Liu SJ, Long HC, Que QW. Relationship between mediastinal lymph node metastasis and prognosis of lung cancer[J]. Hainan Yi Xue Yuan Xue Bao, 2010, 16(7): 884-6, 894.[刘泗军, 龙鸿川, 阙 奇伟. 肺癌纵隔淋巴结转移与预后的关系分析[J]. 海南医学院 学报, 2010, 16(7): 884-6, 894.]
|